A detailed history of Black Rock Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,139,881 shares of VNDA stock, worth $46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,139,881
Previous 8,346,367 2.47%
Holding current value
$46 Million
Previous $35.2 Million 5.02%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$3.47 - $4.61 $716,506 - $951,900
-206,486 Reduced 2.47%
8,139,881 $33.5 Million
Q4 2023

Feb 13, 2024

BUY
$3.38 - $4.58 $5.36 Million - $7.27 Million
1,587,250 Added 23.48%
8,346,367 $35.2 Million
Q3 2023

Nov 13, 2023

SELL
$4.28 - $6.57 $17.3 Million - $26.6 Million
-4,050,899 Reduced 37.47%
6,759,117 $29.2 Million
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $4.2 Million - $4.94 Million
711,086 Added 7.04%
10,810,016 $71.2 Million
Q1 2023

May 12, 2023

SELL
$6.18 - $7.99 $1.41 Million - $1.82 Million
-227,684 Reduced 2.2%
10,098,930 $68.6 Million
Q4 2022

Feb 13, 2023

BUY
$6.87 - $10.96 $3.64 Million - $5.81 Million
529,981 Added 5.41%
10,326,614 $76.3 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $1.08 Million - $1.34 Million
114,055 Added 1.18%
9,796,633 $96.8 Million
Q2 2022

Aug 12, 2022

SELL
$9.31 - $11.84 $605,531 - $770,085
-65,041 Reduced 0.67%
9,682,578 $106 Million
Q1 2022

May 12, 2022

SELL
$10.84 - $16.55 $842,875 - $1.29 Million
-77,756 Reduced 0.79%
9,747,619 $110 Million
Q4 2021

Feb 10, 2022

BUY
$15.69 - $21.14 $1.93 Million - $2.61 Million
123,253 Added 1.27%
9,825,375 $154 Million
Q3 2021

Nov 09, 2021

SELL
$15.35 - $21.27 $2.52 Million - $3.5 Million
-164,417 Reduced 1.67%
9,702,122 $166 Million
Q2 2021

Aug 11, 2021

BUY
$15.71 - $21.51 $155 Million - $212 Million
9,866,539 New
9,866,539 $212 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $320M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.